Kazia Therapeutics (KZIA) Enterprise Value (2009 - 2025)
Kazia Therapeutics (KZIA) posted Enterprise Value of -$45.1 million for Q4 2025, down 1521.45% on a QoQ basis from -$2.8 million in Q2 2025, and down 1262.38% year-over-year from $3.9 million in Q4 2024.
Kazia Therapeutics (KZIA) Enterprise Value (2009 - 2025) Analysis & Trends
Kazia Therapeutics' Enterprise Value history runs 17 years deep, the most recent figure standing at -$45.1 million for Q4 2025.
- Quarterly Enterprise Value fell 1262.38% year-over-year to -$45.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$45.1 million (down 1262.38% YoY) and the FY2025 annual result came in at -$2.8 million, down 148.36% from the prior year.
- Enterprise Value was -$45.1 million for Q4 2025 at Kazia Therapeutics, down from -$2.8 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$1.1 million in Q2 2024 and bottomed at -$45.1 million in Q4 2025.
- A 5-year average of -$10.4 million and a median of -$3.4 million in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value surged 79.91% — and 2025, when it slumped 1262.38%.
- Kazia Therapeutics' Enterprise Value stood at -$11.1 million in 2021, then soared by 73.93% to -$2.9 million in 2022, then grew by 21.51% to -$2.3 million in 2023, then plunged by 46.26% to -$3.3 million in 2024, then tumbled by 1262.38% to -$45.1 million in 2025.
- Business Quant data shows KZIA's Enterprise Value at -$45.1 million in Q4 2025, -$2.8 million in Q2 2025, and -$3.3 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Kazia Therapeutics | 4.11 Mn | 4.11 Mn | - | -45.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -45.12 Mn |
| Jun 30, 2025 | -2.78 Mn |
| Dec 31, 2024 | -3.31 Mn |
| Jun 30, 2024 | -1.12 Mn |
| Dec 31, 2023 | -2.26 Mn |
| Jun 30, 2023 | -3.50 Mn |
| Dec 31, 2022 | -2.88 Mn |
| Jun 30, 2022 | -5.27 Mn |
| Dec 31, 2021 | -11.07 Mn |
| Jun 30, 2021 | -26.25 Mn |
| Dec 31, 2020 | -20.00 Mn |
| Jun 30, 2020 | -10.66 Mn |
| Dec 31, 2019 | -4.28 Mn |
| Jun 30, 2019 | -3.81 Mn |
| Dec 31, 2018 | -2.75 Mn |
| Jun 30, 2018 | -4.51 Mn |
| Jun 30, 2017 | -10.86 Mn |
| Dec 31, 2016 | -4.98 Mn |
| Jun 30, 2016 | -24.98 Mn |
| Dec 31, 2015 | -32.15 Mn |